Advancing Bispecific Discovery & Development
Time: 3:00 pm
day: Conference Day One
Details:
• Identifying the key challenges in optimizing bispecific antibody candidates using tumour models
• Exploring a method to enhance the therapeutic potential of bispecific antibodies through rational design and in vivo validation in tumour models
• Discussing strategies for effectively translating preclinical data into clinical applications, including safety assessment and dosing strategies
